Albania vs Croatia: HIV/AIDS deaths averted by antiretroviral therapy
Albania
51.15 deaths
in 2024
Croatia
62.42 deaths
in 2024
Albania rank
135th
Croatia rank
132nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Albania
- Croatia
How they compare
Croatia currently reports 62.42 deaths against 51.15 deaths in Albania, a difference of 11.27 deaths.
That makes Croatia's figure about 1.2 times Albania's.
Across all 35 years both countries report, Croatia has been ahead every year.
Albania ranks 135th and Croatia ranks 132nd of 157 countries.
Croatia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Albania | Croatia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 5.5 deaths | 5.5 deaths | Croatia |
| 2000s | 4.99 deaths | 30.97 deaths | 25.98 deaths | Croatia |
| 2010s | 35.4 deaths | 54.21 deaths | 18.82 deaths | Croatia |
| 2020s | 48.41 deaths | 61.72 deaths | 13.31 deaths | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Albania or Croatia?
- Croatia, at 62.42 deaths against 51.15 deaths in Albania as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Albania and Croatia?
- 11.27 deaths, with Croatia ahead.
- How many years of comparable data are there for Albania and Croatia?
- 35 years are reported by both, from 1990 to 2024.
- How do Albania and Croatia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Albania ranks 135th and Croatia ranks 132nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.